Paiva Edison F, Perondi Maria Beatriz M, Kern Karl B, Berg Robert A, Timerman Sergio, Cardoso Luiz F, Ramirez José Antonio F
Heart Institute, University of São Paulo School of Medicine, CEP 05411-001, SP, São Paulo, Brazil.
Resuscitation. 2003 Aug;58(2):203-8. doi: 10.1016/s0300-9572(03)00148-5.
Amiodarone has been shown to be superior to both placebo and lidocaine in improving survival to hospital admission for victims of out-of-hospital refractory ventricular fibrillation. Concern had been expressed about the known vasodilatatory effects of amiodarone if given without precedent vasoconstrictive medications. The haemodynamic effects of intravenous amiodarone administered during ongoing CPR have not been systemically investigated. Our intention was to verify if amiodarone alone produced significantly lower resuscitation haemodynamics than did either adrenaline (epinephrine) alone or the combination of amiodarone and adrenaline.
Prospective, randomized, comparative study.
Research laboratory of a medical school.
Thirty mongrel dogs.
After 8 min of untreated VF, defibrillation was attempted once at 3 J/kg and external chest compressions and ventilation started. Those animals resistant to the defibrillation attempt were randomized, ten to an adrenaline (0.02 mg/kg) group, ten to an amiodarone (5 mg/kg) group, and ten to a group receiving a combination of both drugs.
Aortic systolic and diastolic, and coronary perfusion pressures were all significantly lower in the group receiving amiodarone alone than in the other two groups. Amiodarone combined with adrenaline produced pressures during CPR similar to adrenaline alone.
Amiodarone can be safely administered simultaneously in combination with adrenaline and such a combination results in similar haemodynamic support as adrenaline alone. Amiodarone administered alone produces significantly lower coronary perfusion pressure than when combined with adrenaline.
对于院外难治性室颤患者,胺碘酮在提高入院存活率方面已被证明优于安慰剂和利多卡因。如果在没有预先使用血管收缩药物的情况下给予胺碘酮,人们对其已知的血管扩张作用表示担忧。在持续心肺复苏期间静脉注射胺碘酮的血流动力学效应尚未得到系统研究。我们的目的是验证单独使用胺碘酮是否比单独使用肾上腺素(副肾素)或胺碘酮与肾上腺素联合使用产生的复苏血流动力学显著更低。
前瞻性、随机、对照研究。
一所医学院的研究实验室。
30只杂种犬。
在未经治疗的室颤8分钟后,以3焦耳/千克的能量尝试一次除颤,并开始进行胸外按压和通气。那些对除颤尝试有抵抗的动物被随机分组,10只进入肾上腺素(0.02毫克/千克)组,10只进入胺碘酮(5毫克/千克)组,10只进入接受两种药物联合使用的组。
单独接受胺碘酮治疗的组的主动脉收缩压、舒张压和冠状动脉灌注压均显著低于其他两组。胺碘酮与肾上腺素联合使用在心肺复苏期间产生的压力与单独使用肾上腺素时相似。
胺碘酮可与肾上腺素同时安全给药,这种联合使用产生的血流动力学支持与单独使用肾上腺素相似。单独使用胺碘酮时产生的冠状动脉灌注压显著低于与肾上腺素联合使用时。